iScience (Dec 2020)

An In Vitro Whole-Organ Liver Engineering for Testing of Genetic Therapies

  • Maëlle Lorvellec,
  • Alessandro Filippo Pellegata,
  • Alice Maestri,
  • Chiara Turchetta,
  • Elena Alvarez Mediavilla,
  • Soichi Shibuya,
  • Brendan Jones,
  • Federico Scottoni,
  • Dany P. Perocheau,
  • Andrei Claudiu Cozmescu,
  • Juliette M. Delhove,
  • Daniel Kysh,
  • Asllan Gjinovci,
  • John R. Counsell,
  • Wendy E. Heywood,
  • Kevin Mills,
  • Tristan R. McKay,
  • Paolo De Coppi,
  • Paul Gissen

Journal volume & issue
Vol. 23, no. 12
p. 101808

Abstract

Read online

Summary: Explosion of gene therapy approaches for treating rare monogenic and common liver disorders created an urgent need for disease models able to replicate human liver cellular environment. Available models lack 3D liver structure or are unable to survive in long-term culture. We aimed to generate and test a 3D culture system that allows long-term maintenance of human liver cell characteristics.The in vitro whole-organ “Bioreactor grown Artificial Liver Model” (BALM) employs a custom-designed bioreactor for long-term 3D culture of human induced pluripotent stem cells-derived hepatocyte-like cells (hiHEPs) in a mouse decellularized liver scaffold. Adeno-associated viral (AAV) and lentiviral (LV) vectors were introduced by intravascular injection.Substantial AAV and LV transgene expression in the BALM-grown hiHEPs was detected. Measurement of secreted proteins in the media allowed non-invasive monitoring of the system.We demonstrated that humanized whole-organ BALM is a valuable tool to generate pre-clinical data for investigational medicinal products.

Keywords